BRIEF-Cytokinetics starts phase 1B clinical trial of CK-2127107 in elderly subjects By: Reuters: Company News June 29, 2017 at 07:47 AM EDT * Cytokinetics announces start of phase 1B clinical trial of CK-2127107 in elderly subjects with limited mobility Read More >> Related Stocks: Cytokinetics